Back to HRT FINANCIAL LP HRT FINANCIAL LP

NSRXNSRX
2 quarters

Position history for HRT FINANCIAL LPHRT FINANCIAL LP's holdings in NASUS PHARMA LTD

No. HRT Financial exited its NSRX (Nasus Pharma) position in Q2 2026. Its Q1 2026 13F listed 38,897 shares worth $86,000. HRT Financial first reported NSRX in Q1 2026 and held it in 1 quarterly 13F filing.

Final Value

$0

Final Shares

0

Total Value Change

-$86,000

Total Shares Change

-38,897

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$3.50
0
2026-Q1
New
38,897
-
$86,0000.0%$2.22
30

Other major holders of NSRX: BALYASNY ASSET MANAGEMENT L.P., Hudson Bay Capital Management LP, CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used